6th Annual LRI Scientific Conference
October 19th and 20th 2006
Exciting Advances Reported by 2004 & 2005 Recipients
"Meeting other investigators and particularly 'behind the scenes' donors, patients, LRI staff . . . knowing first-hand what they do, and feeling their compassionate enthusiasm for not only the research but also the patients, made me appreciate further the depth and breadth of the LRI-funded research and reminded me again the ultimate mission of our research—to help patients with lupus."
–LRI researcher Chau-Ching Liu, MD, PhD, University of Pittsburgh School of Medicine
"I am already looking forward to next year's conference."
–LRI researcher Stephen C. Pelsue, PhD, University of Southern Maine, Portland
More than 40 scientists from around the country presented and discussed findings on cutting-edge lupus research, viewed posters, and took part in informal discussions among colleagues at the LRI's annual scientific conference at the Yale Club in New York.
The October 19th and 20th meeting gave grant recipients a unique forum for exchanging ideas and building collaborations—and an invaluable opportunity to witness the intersection of basic science and clinical care.
Formal presentations and lively poster session enabled LRI scientists to update their colleagues on findings in biomarkers and hormones, renal disease, cardiovascular complications and disease regulation, and more.
Cornerstone scientific addresses on this year's timely conference theme--innate versus acquired immunity—were given by Ruslan Medzhitov, PhD, of Yale University School of Medicine, Mark Shlomchik, MD, PhD, of Yale University School of Medicine, and Ann Marshak-Rothstein, PhD, of Boston University School of Medicine.
Day 1 ended with a dinner address by NIH Director Elias A. Zerhouni, MD, followed the next day by an open panel discussion with representatives from academia as well as pharmaceutical and biotechnology companies on the prospects for drug development in the coming years.